The process of treating HIV patients in Africa has improved markedly due to cooperation between pharmaceutical companies, which has led to increasing access to higher quality medicines.

South Africa will likely face a number of challenges due to the effects of its AIDS-related excess mortality; the country needs programs that deliver a broader variety of services than are currently offered if it hopes to emerge as a prosperous regional power by midcentury.

American Enterprise Institute (AEI) economist  Roger Bate shares his expertise on counterfeit drug networks that pose a growing threat to combating diseases like malaria.

Testimony to thePresident’s Advisory Council on HIV/AIDS (PACHA), the first part emphasizing the strainrelated to tariffs on medicines, markups and access to essential medical interventions and the second part regarding mission creep in aid agencies.

On the correlation between tariffs and access to medicine in third-world countries.

Over 1.6 million people in the poorest parts of the world are now on antiretroviral treatment to halt the advance of HIV, but in a rush to improve access, mistakes have been made.

Taxes and tariffs on medicines and medical devices need to be eliminated in order to bring down the cots of life-saving medications.

Online registration for this event is now closed. Walk-in registrations will be accepted.

Even though more and more people worldwide are gaining access to AIDS treatment, there has been an apparent decline in the number of companies investing in HIV/AIDS. Why? Could it be that recent policy decisions by the World...